Wolverine Trading
TVRD

Wolverine Trading’s Tvardi Therapeutics TVRD Stock Holding History

Wolverine Trading’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-496
Closed -$258K – 7135
2021
Q2 		$258K Buy
+496
New +$314K ﹤0.01% 4651
2021
Q1 		– Sell
-452
Closed -$309K – 6521
2020
Q4 		$250K Buy
452
+129
+40% +$67.6K ﹤0.01% 3972
2020
Q3 		$144K Sell
323
-397
-55% -$231K ﹤0.01% 3994
2020
Q2 		$435K Sell
720
-100
-12% -$55.2K ﹤0.01% 2897
2020
Q1 		$392K Buy
820
+216
+36% +$117K ﹤0.01% 2923
2019
Q4 		$357K Sell
604
-180
-23% -$126K ﹤0.01% 3397
2019
Q3 		$526K Sell
784
-413
-35% -$343K ﹤0.01% 2579
2019
Q2 		$926K Sell
1,197
-297
-20% -$209K ﹤0.01% 2114
2019
Q1 		$1.05M Buy
1,494
+12
+0.8% +$7.18K ﹤0.01% 2026
2018
Q4 		$678K Buy
1,482
+433
+41% +$279K ﹤0.01% 2349
2018
Q3 		$904K Buy
1,049
+743
+243% +$536K ﹤0.01% 2465
2018
Q2 		$136K Hold
306
– – ﹤0.01% 4602
2018
Q1 		$136K Buy
+306
New +$148K ﹤0.01% 4602

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wolverine Trading's TVRD Position: Q3 2021 in Review

Wolverine Trading sold out of Tvardi Therapeutics (TVRD) in Q3 2021, closing a stake of 496 shares — an estimated $258K sold.

Wolverine Trading first reported a position in TVRD in Q1 2018 and held it in 13 quarters. The position peaked at $1.05M in Q1 2019. 168 funds tracked by Wall St. Rank hold TVRD as of Q3 2021.

  • Wolverine Trading reported no remaining Tvardi Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 496 Tvardi Therapeutics shares in Q3 2021, an estimated $258K.
  • Wolverine Trading first reported a position in Tvardi Therapeutics in Q1 2018 and held it in 13 quarters.
  • Wolverine Trading's Tvardi Therapeutics position peaked at $1.05M in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.